The American journal of the medical sciences
-
According to reports, coronavirus disease 2019 (COVID-19) is associated with various complications, including hematological abnormalities. Lymphopenia and thrombocytopenia have been recognized as common hematological abnormalities. Moreover, some reports have shown cases of neutropenia occurring during or after infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). ⋯ This will allow for effective therapeutic intervention and appropriate disease management in challenging conditions. In this study, our aim was to conduct a comprehensive review of the current literature on neutropenia during or after SARS-CoV2 infection. Furthermore, we assessed whether there have been any documented cases of immune-mediated neutropenia following COVID-19 and if the appropriate laboratory investigations have been carried out in these patients.
-
Ubiquitin-conjugating enzymes (E2s) participate in various tumor-promoting processes. UBE2Q1 is a member of the E2 family. This research aimed to detect the expression level of UBE2Q1 in human lung adenocarcinoma and to study its malignant biological function. ⋯ UBE2Q1 may serve as a prognostic biomarker and a new therapeutic target of lung adenocarcinoma.
-
Letter Case Reports
Swyer-James-Macleod Syndrome: A Rare and Easily Missed Diagnosis Case.
-
Letter Case Reports
Tamponade physiology related to a large pleural effusion.
-
Letter Case Reports
A rare case of intravenous leiomyomatosis extending to inferior vena cava.